These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25092225)

  • 1. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Kumareswaran K; Hovorka R
    Comput Methods Programs Biomed; 2014 Nov; 117(2):298-307. PubMed ID: 25092225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Wilinska ME; Hovorka R
    Biomed Eng Online; 2015 Mar; 14():19. PubMed ID: 25889091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial.
    Ruan Y; Elleri D; Allen JM; Tauschmann M; Wilinska ME; Dunger DB; Hovorka R
    Diabetologia; 2015 Apr; 58(4):687-90. PubMed ID: 25537835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
    Luzio S; Peter R; Dunseath GJ; Mustafa L; Owens DR
    Diabetes Res Clin Pract; 2008 Feb; 79(2):269-75. PubMed ID: 18164094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
    Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
    Heinemann L; Nosek L; Flacke F; Albus K; Krasner A; Pichotta P; Heise T; Steiner S
    Diabetes Obes Metab; 2012 Mar; 14(3):222-7. PubMed ID: 21981286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in intrasubject variability in the pharmacokinetic response to insulin after subcutaneous co-administration with recombinant human hyaluronidase in healthy volunteers.
    Morrow L; Muchmore DB; Ludington EA; Vaughn DE; Hompesch M
    Diabetes Technol Ther; 2011 Oct; 13(10):1039-45. PubMed ID: 21714645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin.
    Wilinska ME; Chassin LJ; Schaller HC; Schaupp L; Pieber TR; Hovorka R
    IEEE Trans Biomed Eng; 2005 Jan; 52(1):3-12. PubMed ID: 15651559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of the different cross-reactivities of anti-insulin antibodies to insulin lispro to evaluate endogenous insulin secretion.
    Yoshida R; Ohkubo K; Akehi Y; Harada S; Shinohara K; Kawashima H; Ono J; Matsunaga A
    Clin Chim Acta; 2013 Jan; 415():250-4. PubMed ID: 23159841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Bally L; Gubler P; Thabit H; Hartnell S; Ruan Y; Wilinska ME; Evans ML; Semmo M; Vogt B; Coll AP; Stettler C; Hovorka R
    Kidney Int; 2019 Sep; 96(3):593-596. PubMed ID: 31133457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial neural networks for closed loop control of in silico and ad hoc type 1 diabetes.
    Fernandez de Canete J; Gonzalez-Perez S; Ramos-Diaz JC
    Comput Methods Programs Biomed; 2012 Apr; 106(1):55-66. PubMed ID: 22178070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.
    Reichel A; Rietzsch H; Köhler HJ; Pfützner A; Gudat U; Schulze J
    Exp Clin Endocrinol Diabetes; 1998; 106(3):168-72. PubMed ID: 9710355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Day-to-Day Variability of Glucose-Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery.
    Yue Ruan ; Wilinska ME; Thabit H; Hovorka R
    IEEE Trans Biomed Eng; 2017 Jun; 64(6):1412-1419. PubMed ID: 28113240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus.
    Radziuk J; Pye S
    Diabetologia; 2001 Aug; 44(8):983-91. PubMed ID: 11484075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Subcutaneous Regular Insulin and Lispro Insulin in Diabetics Receiving Continuous Nutrition: A Numerical Study.
    Stull MC; Strilka RJ; Clemens MS; Armen SB
    J Diabetes Sci Technol; 2015 Jun; 10(1):137-44. PubMed ID: 26134836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.